Results 91 to 100 of about 32,413 (228)
Influenza and Other Respiratory Viruses, Volume 20, Issue 7, July 2026.ABSTRACT Background The 8th International Society for Respiratory Viruses (ISRV) Antiviral Group Conference, held jointly with the 3rd International Meeting on Respiratory Pathogens in Singapore (17–20 September 2025), examined evolving approaches to prevention and management of respiratory infections.
Narmadha Morvil +5 more
wiley +1 more source
, 2014 BACKGROUND: The Gambia introduced seven-valent pneumococcal conjugate vaccine (PCV) in August 2009 and switched to 13-valent PCV in April 2011. In April 2009 monovalent hepatitis B and combined Diphtheria-Tetanus-Pertussis and Haemophilus influenzae type
Lowe-Jallow, Y +6 more
core +1 more source
Immune persistence after pertussis vaccination
Human Vaccines & Immunotherapeutics, 2017 Pertussis is one of the most prevalent vaccine-preventable diseases worldwide. The true infection rate is significantly higher than the reported incidence rate.
Zhiyun Chen, Qiushui He
doaj +1 more source
, 2007 AIMS: Information on subjects who had at least three immunisations against pertussis was provided by longitudinal data from the 1970 British Cohort Study (BCS70) and used to assess whether three whole-cell pertussis (wP) immunisations given within less ...
Ehlin, A. +2 more
core +2 more sources
Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains [PDF]
, 2019 To add new insight to our previous work on the molecular epidemiology of Bordetella pertussis in Argentina, the prn and ptxS1 gene sequences and pulsed-field gel electrophoresis (PFGE) profiles of 57 clinical isolates obtained during two periods, 1969 to
Bottero, Daniela +12 more
core
Scaling-up vaccine production: implementation aspects of a biomass growth observer and controller
, 2009 This study considers two aspects of the implementation of a biomass growth observer and specific growth rate controller in scale-up from small- to pilot-scale bioreactors towards a feasible bulk production process for whole-cell vaccine against whooping ...
IJssel, J., van den +8 more
core +1 more source
The role of B. pertussis vaccine antigen gene variants in pertussis resurgence and possible consequences for vaccine development [PDF]
, 2016 Whooping cough, or pertussis, caused by Bordetella pertussis is considered resurgent in a number of countries world-wide, despite continued high level vaccine coverage.
Preston, Andrew
core +1 more source
The public health impact of malaria vaccine RTS,S in malaria endemic Africa: country-specific predictions using 18 month follow-up Phase III data and simulation models [PDF]
, 2015 The RTS,S/AS01 malaria vaccine candidate recently completed Phase III trials in 11 African sites. Recommendations for its deployment will partly depend on predictions of public health impact in endemic countries.
Katya Galactionova +9 more
core +1 more source
Household survey of hepatitis B vaccine coverage among Brazilian children
, 2009 We conducted a multi-stage household cluster survey to calculate hepatitis B vaccine coverage among children 18-30 months of age in 27 Brazilian cities.
FLANNERY, Brendan +4 more
core +1 more source